Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Seattle, WA
SEC filing record 1 source field available
Fiscal year end
31 December
ALPINE IMMUNE SCIENCES, INC. has filed 646 SEC EDGAR filings since 25 Nov 2014

SEC filing history

Showing 501-525 of 646 matching filings.

Per page
25
Current page
21
8-K File 001-37449

8-K

Filing date
17 May 2017
Reporting date
15 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
11 May 2017
Reporting date
09 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
3

OWNERSHIP DOCUMENT

Filing date
11 May 2017
Reporting date
08 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
11 May 2017
Reporting date
08 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
10 May 2017
Reporting date
09 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
09 May 2017
Reporting date
05 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
09 May 2017
Reporting date
05 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
08 May 2017
Reporting date
04 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37449

8-K

Filing date
01 May 2017
Reporting date
01 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37449

8-K

Filing date
28 Apr 2017
Reporting date
28 Apr 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
425 File 001-37449

8-K

Filing date
28 Apr 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-88896

SC 13D/A filing

Filing date
25 Apr 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
425 File 001-37449

425

Filing date
19 Apr 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37449

8-K

Filing date
18 Apr 2017
Reporting date
18 Apr 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
425 File 001-37449

8-K

Filing date
18 Apr 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-37449

DEF 14A

Filing date
06 Apr 2017
Reporting date
15 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37449

8-K

Filing date
23 Feb 2017
Reporting date
23 Feb 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88896

AMENDMENT NO. 2 TO THE SCHEDULE 13G

Filing date
14 Feb 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37449

8-K

Filing date
13 Feb 2017
Reporting date
13 Feb 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88896

SEC SCHEDULE 13G

Filing date
10 Feb 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88896

SEC SCHEDULE 13G

Filing date
09 Feb 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
23 Jan 2017
Reporting date
12 Jan 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
23 Jan 2017
Reporting date
12 Jan 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .